Surprisingly, BIRC3 was reported to upregulate after F. nucleatum infection and promote chemoresistance to 5-Fu in CRC (Zhang et al., 2019), which suggested the reliability of our analysis. Here, BIRC3 is linked to colorectal carcinoma.